Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Medicine | 2 | 2019 | 46 | 1.320 |
Why?
|
| Asthma | 10 | 2019 | 955 | 0.780 |
Why?
|
| Cystic Fibrosis | 13 | 2014 | 112 | 0.780 |
Why?
|
| Pediatrics | 1 | 2019 | 344 | 0.510 |
Why?
|
| Child | 24 | 2019 | 6927 | 0.330 |
Why?
|
| Child, Preschool | 10 | 2019 | 3612 | 0.310 |
Why?
|
| Infant | 7 | 2019 | 3046 | 0.270 |
Why?
|
| Echocardiography | 6 | 1990 | 911 | 0.250 |
Why?
|
| Adolescent | 20 | 2019 | 8981 | 0.220 |
Why?
|
| Genetic Counseling | 2 | 2014 | 100 | 0.210 |
Why?
|
| Cardiomegaly | 4 | 1990 | 111 | 0.210 |
Why?
|
| Disclosure | 2 | 2014 | 108 | 0.170 |
Why?
|
| Anemia, Sickle Cell | 2 | 1990 | 131 | 0.160 |
Why?
|
| Respiration | 2 | 2013 | 262 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2013 | 2271 | 0.150 |
Why?
|
| Lung | 4 | 2013 | 1170 | 0.140 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 8 | 0.120 |
Why?
|
| beta-Defensins | 1 | 2013 | 12 | 0.120 |
Why?
|
| Humans | 33 | 2019 | 86643 | 0.120 |
Why?
|
| Genotype | 4 | 2008 | 1851 | 0.120 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 37 | 0.120 |
Why?
|
| Chemokines, CC | 1 | 2013 | 34 | 0.120 |
Why?
|
| Genetic Testing | 3 | 2014 | 535 | 0.110 |
Why?
|
| Consensus | 1 | 2014 | 335 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2004 | 1074 | 0.110 |
Why?
|
| Respiratory Function Tests | 4 | 2013 | 136 | 0.100 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2003 | 62 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2013 | 2357 | 0.100 |
Why?
|
| Agriculture | 1 | 2011 | 38 | 0.100 |
Why?
|
| Sweat | 1 | 2011 | 4 | 0.100 |
Why?
|
| Rural Population | 1 | 2011 | 136 | 0.100 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2008 | 77 | 0.090 |
Why?
|
| Comprehension | 1 | 2011 | 79 | 0.090 |
Why?
|
| Neonatal Screening | 1 | 2011 | 59 | 0.090 |
Why?
|
| Male | 22 | 2014 | 40965 | 0.090 |
Why?
|
| Erythrocyte Transfusion | 1 | 1990 | 60 | 0.090 |
Why?
|
| Female | 23 | 2014 | 44532 | 0.090 |
Why?
|
| Adult | 20 | 2013 | 25648 | 0.090 |
Why?
|
| Blood Transfusion | 1 | 1990 | 157 | 0.090 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 1979 | 67 | 0.080 |
Why?
|
| Parents | 1 | 2011 | 272 | 0.080 |
Why?
|
| Lymphangiectasis, Intestinal | 1 | 1986 | 2 | 0.070 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1986 | 6 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2008 | 234 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 1986 | 45 | 0.070 |
Why?
|
| Hemodynamics | 1 | 1990 | 710 | 0.070 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1986 | 41 | 0.070 |
Why?
|
| Allergens | 2 | 2005 | 179 | 0.070 |
Why?
|
| Genetic Carrier Screening | 3 | 2014 | 60 | 0.070 |
Why?
|
| Skin Tests | 2 | 2003 | 44 | 0.070 |
Why?
|
| Eukaryota | 1 | 2005 | 44 | 0.070 |
Why?
|
| Family Health | 2 | 2003 | 162 | 0.070 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2005 | 11 | 0.070 |
Why?
|
| Docosahexaenoic Acids | 1 | 2005 | 31 | 0.070 |
Why?
|
| Integrin beta3 | 1 | 2005 | 30 | 0.070 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 1984 | 8 | 0.060 |
Why?
|
| Triglycerides | 1 | 2005 | 232 | 0.060 |
Why?
|
| Tobramycin | 1 | 2004 | 10 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2004 | 125 | 0.060 |
Why?
|
| Lung Abscess | 1 | 1983 | 5 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 203 | 0.060 |
Why?
|
| Inhalation | 1 | 1983 | 31 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2501 | 0.060 |
Why?
|
| Immunoglobulin E | 1 | 2003 | 144 | 0.060 |
Why?
|
| HLA Antigens | 1 | 2004 | 232 | 0.060 |
Why?
|
| Lung Diseases | 1 | 2004 | 263 | 0.050 |
Why?
|
| Cimetidine | 2 | 1984 | 7 | 0.050 |
Why?
|
| Heterozygote | 1 | 2003 | 365 | 0.050 |
Why?
|
| Hyperthyroidism | 1 | 1982 | 75 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2001 | 62 | 0.050 |
Why?
|
| Pancreatic Extracts | 1 | 1980 | 1 | 0.050 |
Why?
|
| Pulmonary Heart Disease | 1 | 1980 | 4 | 0.050 |
Why?
|
| Founder Effect | 2 | 2014 | 104 | 0.050 |
Why?
|
| Guanidines | 1 | 1980 | 31 | 0.050 |
Why?
|
| Cockroaches | 1 | 2000 | 10 | 0.050 |
Why?
|
| HLA-DR Antigens | 1 | 2000 | 61 | 0.050 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2000 | 9 | 0.050 |
Why?
|
| Insect Proteins | 1 | 2000 | 88 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1982 | 187 | 0.040 |
Why?
|
| Environment | 1 | 2001 | 219 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2001 | 623 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 746 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2011 | 2379 | 0.040 |
Why?
|
| Genome, Human | 1 | 2003 | 756 | 0.040 |
Why?
|
| Forced Expiratory Volume | 2 | 1994 | 122 | 0.040 |
Why?
|
| Stroke Volume | 3 | 1990 | 456 | 0.040 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1978 | 19 | 0.040 |
Why?
|
| Aorta | 1 | 1979 | 280 | 0.040 |
Why?
|
| Heart Atria | 1 | 1979 | 250 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2005 | 1351 | 0.040 |
Why?
|
| Cardiac Volume | 2 | 1990 | 53 | 0.040 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 1994 | 57 | 0.040 |
Why?
|
| Expectorants | 1 | 1996 | 6 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 1994 | 1196 | 0.040 |
Why?
|
| Deoxyribonuclease I | 1 | 1996 | 28 | 0.040 |
Why?
|
| Genetic Research | 1 | 2014 | 17 | 0.030 |
Why?
|
| Phenotype | 3 | 2008 | 2378 | 0.030 |
Why?
|
| Homozygote | 1 | 1994 | 200 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 69 | 0.030 |
Why?
|
| Fatty Acids | 2 | 1986 | 130 | 0.030 |
Why?
|
| Lod Score | 2 | 2003 | 152 | 0.030 |
Why?
|
| Nuclear Family | 2 | 2003 | 92 | 0.030 |
Why?
|
| Body Weight | 2 | 1986 | 459 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2008 | 1805 | 0.030 |
Why?
|
| Mutation | 2 | 1994 | 3968 | 0.030 |
Why?
|
| South Dakota | 1 | 2011 | 47 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2014 | 839 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 351 | 0.020 |
Why?
|
| Hemoglobinometry | 1 | 1990 | 9 | 0.020 |
Why?
|
| Health Education | 1 | 2011 | 101 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 5976 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 18415 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 1990 | 244 | 0.020 |
Why?
|
| United States | 3 | 2013 | 6672 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1990 | 143 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 3030 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 6509 | 0.020 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Adipokines | 1 | 2008 | 19 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2008 | 32 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1054 | 0.020 |
Why?
|
| Middle Aged | 3 | 2013 | 25028 | 0.020 |
Why?
|
| Lectins | 1 | 2008 | 84 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 1990 | 999 | 0.020 |
Why?
|
| Haplotypes | 2 | 2000 | 642 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1239 | 0.020 |
Why?
|
| Body Constitution | 1 | 1987 | 26 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 1987 | 30 | 0.020 |
Why?
|
| Rosette Formation | 1 | 1986 | 34 | 0.020 |
Why?
|
| Ventricular Function | 1 | 1987 | 53 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 1986 | 3 | 0.020 |
Why?
|
| Linoleic Acid | 1 | 1986 | 5 | 0.020 |
Why?
|
| Alleles | 2 | 2000 | 1128 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 1990 | 592 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1986 | 27 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1986 | 95 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1996 | 894 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2005 | 7 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1986 | 177 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1986 | 148 | 0.020 |
Why?
|
| Prognosis | 1 | 1994 | 3679 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 1982 | 760 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 63 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 1621 | 0.020 |
Why?
|
| Biological Availability | 1 | 2005 | 92 | 0.020 |
Why?
|
| Reference Values | 1 | 1987 | 674 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2005 | 124 | 0.020 |
Why?
|
| Hospitalization | 2 | 2004 | 849 | 0.020 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2005 | 41 | 0.020 |
Why?
|
| Pancreatic Function Tests | 1 | 1984 | 7 | 0.020 |
Why?
|
| Aminobenzoates | 1 | 1984 | 5 | 0.020 |
Why?
|
| Safety | 1 | 2005 | 152 | 0.020 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 1984 | 6 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2005 | 110 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2005 | 128 | 0.020 |
Why?
|
| HLA-G Antigens | 1 | 2004 | 52 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2000 | 677 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1986 | 464 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 307 | 0.020 |
Why?
|
| Cough | 1 | 2004 | 54 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3640 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 188 | 0.020 |
Why?
|
| Fever | 1 | 2004 | 125 | 0.010 |
Why?
|
| Eubacterium | 1 | 1983 | 2 | 0.010 |
Why?
|
| Peptostreptococcus | 1 | 1983 | 3 | 0.010 |
Why?
|
| Family Relations | 1 | 2003 | 35 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 193 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1987 | 1673 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 372 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 1718 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1982 | 156 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 43 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1961 | 0.010 |
Why?
|
| Family | 1 | 2003 | 311 | 0.010 |
Why?
|
| Africa | 1 | 2001 | 98 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2001 | 66 | 0.010 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 1980 | 1 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1538 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1987 | 1204 | 0.010 |
Why?
|
| Europe | 1 | 2001 | 309 | 0.010 |
Why?
|
| HLA-DRB1 Chains | 1 | 2000 | 28 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1863 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 1230 | 0.010 |
Why?
|
| Christianity | 1 | 2000 | 36 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2001 | 476 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2000 | 79 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 158 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1979 | 36 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1979 | 274 | 0.010 |
Why?
|
| Diastole | 1 | 1979 | 144 | 0.010 |
Why?
|
| Lipids | 1 | 1980 | 269 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 966 | 0.010 |
Why?
|
| Angiography | 1 | 1979 | 208 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2000 | 473 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2004 | 7993 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 526 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 926 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 1979 | 291 | 0.010 |
Why?
|
| Celiac Disease | 1 | 1980 | 203 | 0.010 |
Why?
|
| Decision Making | 1 | 2003 | 642 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1978 | 144 | 0.010 |
Why?
|
| Heart Rate | 1 | 1979 | 492 | 0.010 |
Why?
|
| Aerosols | 1 | 1996 | 44 | 0.010 |
Why?
|
| Heart | 1 | 1979 | 539 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 5210 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1978 | 971 | 0.010 |
Why?
|
| Acute Disease | 1 | 1996 | 826 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 1014 | 0.010 |
Why?
|
| Research | 1 | 1995 | 253 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1982 | 4213 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1992 | 92 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1996 | 1823 | 0.010 |
Why?
|
| Oxygen | 1 | 1996 | 726 | 0.010 |
Why?
|
| Age Factors | 1 | 1995 | 1851 | 0.010 |
Why?
|
| Base Sequence | 1 | 1992 | 2330 | 0.010 |
Why?
|
| Chicago | 1 | 1992 | 1379 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1979 | 8489 | 0.000 |
Why?
|
| Amylases | 1 | 1984 | 13 | 0.000 |
Why?
|
| para-Aminobenzoates | 1 | 1984 | 4 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1984 | 271 | 0.000 |
Why?
|
| Animals | 1 | 2000 | 26582 | 0.000 |
Why?
|